COMPANY
Applied Biologics
Timeline
- Trial start Phase 3: a Prospective, Multicenter, Randomized Controlled Trial, With a Non-randomized Sentinel Cohort, Evaluating the Efficacy of Bioxheal, a Single-layer Placental-derived Biologic in Nonhealing Di source ↗
- Trial start —: Evaluating the Durability of Closure for Diabetic Foot Ulcers Following a Randomized, Controlled, Modified Platform Trial. source ↗
- Trial start Phase 4: A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ul source ↗
- Trial start Phase 4: A Multicenter, Prospective, Clinical Trial Evaluating a Single Layer Amniotic Membrane and Standard of Care Versus Matched Controls in the Management of Nonhealing Pressure Ulcers source ↗
- Trial start Not phased (device or behavioral study): Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care Versus Standard of Care source ↗
- Trial start Phase 2: Safety & Efficacy FloGraft (Micronized Human Amnion Chorion Membrane)® in Adults With Pain Due to OA of the Knee source ↗
- Trial start Not phased (device or behavioral study): Efficacy of an Amniotic Fluid Derived Allograft, (FlōGraft®) in Rotator Cuff Repairs: A Prospective Study source ↗
Upcoming milestones
- 2027-08 (ESTIMATED) · Phase 4 · A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers · NCT07159282
- 2027-08 (ESTIMATED) · Phase 4 · A Multicenter, Prospective, Clinical Trial Evaluating a Single Layer Amniotic Membrane and Standard of Care Versus Matched Controls in the Management of Nonhealing Pressure Ulcers · NCT07126886
- 2027-10 (ESTIMATED) · · Evaluating the Durability of Closure for Diabetic Foot Ulcers Following a Randomized, Controlled, Modified Platform Trial. · NCT07360418
- 2028-11 (ESTIMATED) · Phase 3 · a Prospective, Multicenter, Randomized Controlled Trial, With a Non-randomized Sentinel Cohort, Evaluating the Efficacy of Bioxheal, a Single-layer Placental-derived Biologic in Nonhealing Diabetic Fo · NCT07852338
Clinical trials (lead sponsor) 7
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT07852338 | a Prospective, Multicenter, Randomized Controlled Trial, With a Non-randomized Sentinel Cohort, Evaluating the Efficacy of Bioxheal, a Single-layer Placental-derived Biologic in Nonhealing Diabetic Foot Ulcers | Phase 3 | Recruiting | Oct 8, 2026 | 2028-11 (estimated) |
| NCT07159282 | A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers | Phase 4 | Recruiting | Aug 26, 2025 | 2027-08 (estimated) |
| NCT07126886 | A Multicenter, Prospective, Clinical Trial Evaluating a Single Layer Amniotic Membrane and Standard of Care Versus Matched Controls in the Management of Nonhealing Pressure Ulcers | Phase 4 | Recruiting | Jun 11, 2025 | 2027-08 (estimated) |
| NCT07360418 | Evaluating the Durability of Closure for Diabetic Foot Ulcers Following a Randomized, Controlled, Modified Platform Trial. | Not listed | Recruiting | Oct 16, 2025 | 2027-10 (estimated) |
| NCT06564831 | Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care Versus Standard of Care | Not phased (device or behavioral study) | Recruiting | Sep 20, 2024 | 2025-02 (estimated) |
| NCT03441607 | Safety & Efficacy FloGraft (Micronized Human Amnion Chorion Membrane)® in Adults With Pain Due to OA of the Knee | Phase 2 | Unknown status (ClinicalTrials.gov) | 2018-11 | 2019-02 (estimated) |
| NCT03379324 | Efficacy of an Amniotic Fluid Derived Allograft, (FlōGraft®) in Rotator Cuff Repairs: A Prospective Study | Not phased (device or behavioral study) | Unknown status (ClinicalTrials.gov) | Mar 24, 2017 | Sep 30, 2019 (estimated) |